"Researchers at the University of Calgary are testing high-dose Vitamin B3 (niacin) as an adjunct to standard glioblastoma treatment. Early Phase I/II trial results show 82% of 24 patients had no disease progression at six months. The study aims to rejuvenate immune cells to better attack tumor cells."